跳至主要内容
临床试验/EUCTR2011-004718-40-IT
EUCTR2011-004718-40-IT进行中(未招募)不适用

Activities of Metronidazole + Clotrimazole in the treatment and prophylaxis of recurrent vaginal infections recurrent Candida albicans and Candida albicans spp do not. - MELCOM-1

AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE0 个研究点开始时间: 2012年3月8日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women will be recruited (age range 18-50) with a vaginal infection by Candida albicans and non-albicans Candida spp relapsing recurrent (= 4 events / year) in the acute phase of the disease.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Are not eligible for the study, patients who refuse consent baccalaureate study, in the case of taking birth control and pregnancy.

研究者

发起方
AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE

相似试验

Activities of Metronidazole + Clotrimazole in the... | 临床试验